当前位置: X-MOL 学术Abdom. Radiol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Imaging-guided percutaneous thrombin injection for the treatment of iatrogenic femoral artery pseudoaneurysms.
Abdominal Radiology ( IF 2.3 ) Pub Date : 2019-03-01 , DOI: 10.1007/s00261-019-01923-6
Wendy L Ehieli 1 , Erol Bozdogan 1 , Gemini Janas 1 , Tracy A Jaffe 1 , Chad M Miller 1 , Mustafa R Bashir 1 , Brian C Allen 1
Affiliation  

PURPOSE To evaluate factors that may affect successful ultrasound-guided percutaneous thrombin injection of iatrogenic femoral artery pseudoaneurysms (PSA). MATERIALS AND METHODS This was an IRB-approved, HIPAA-compliant retrospective study of 326 consecutive subjects (138 males, 188 females; mean age 68 years, range 18-95) who underwent thrombin injection for treatment of femoral PSA; follow-up ultrasound was available in 145 subjects. The number of PSA lobes and dimensions, pre-procedure laboratory values (international normalized ratio [INR], activated partial thromboplastin time [aPTT], platelet count), and concomitant anticoagulation therapy were recorded. RESULTS Technical success was achieved in 98.2% (320/326) of subjects. Primary effectiveness (complete thrombosis at 24 h) was achieved in 74.5% (108/145). Twenty-five subjects underwent repeat thrombin injection, successful in 21 subjects, for a total effectiveness rate of 97.0% (129/133). No imaging factor was associated with technique failure, including number of lobes (p = 0.898), largest dimension (p = 0.344), or volume (p = 0.697). No statistically significant difference in pre-procedure INR, aPTT, or platelet count was found between subjects with CT and those with IT (p > 0.138). Anticoagulation therapy was associated with incomplete thrombosis (35.5% [38/107] for CT vs. 63.9% [23/26] for IT; p = 0.002). CONCLUSION Imaging-guided percutaneous thrombin injection has high technical success and effectiveness rates for the treatment of iatrogenic femoral artery PSA. Anticoagulation therapy was the only factor associated with incomplete thrombosis.

中文翻译:

影像引导下经皮凝血酶注射液治疗医源性股动脉假性动脉瘤。

目的评估可能会影响成功的超声引导下经皮凝血酶注射医源性股动脉假性动脉瘤(PSA)的因素。材料与方法这是一项IRB批准的,符合HIPAA要求的回顾性研究,研究对象是326例接受凝血酶注射治疗股骨PSA的连续受试者(138例男性,188例女性,平均年龄68岁,范围18-95)。145位受试者进行了随访超声检查。记录PSA肺叶的数量和大小,术前实验室检查值(国际标准化比值[INR],活化的部分凝血活酶时间[aPTT],血小板计数)以及伴随的抗凝治疗。结果98.2%(320/326)的受试者获得了技术成功。初步有效性(24小时完全血栓形成)达到74.5%(108/145)。25名受试者接受了重复凝血酶注射,其中21名受试者成功,总有效率为97.0%(129/133)。没有影像学因素与技术失败相关,包括肺叶数量(p = 0.898),最大尺寸(p = 0.344)或体积(p = 0.697)。在CT和IT受试者之间,术前INR,aPTT或血小板计数无统计学差异(p> 0.138)。抗凝治疗与血栓形成不完全相关(CT为35.5%[38/107],IT为63.9%[23/26]; p = 0.002)。结论影像引导下经皮凝血酶注射液治疗医源性股动脉PSA具有很高的技术成功率和有效率。抗凝治疗是与不完全血栓形成相关的唯一因素。在21名受试者中获得成功,总有效率97.0%(129/133)。没有影像学因素与技术失败相关,包括肺叶数量(p = 0.898),最大尺寸(p = 0.344)或体积(p = 0.697)。在CT和IT受试者之间,术前INR,aPTT或血小板计数无统计学差异(p> 0.138)。抗凝治疗与血栓形成不完全相关(CT为35.5%[38/107],IT为63.9%[23/26]; p = 0.002)。结论影像引导下经皮凝血酶注射液治疗医源性股动脉PSA具有很高的技术成功率和有效率。抗凝治疗是与不完全血栓形成相关的唯一因素。在21名受试者中获得成功,总有效率97.0%(129/133)。没有影像学因素与技术失败相关,包括肺叶数量(p = 0.898),最大尺寸(p = 0.344)或体积(p = 0.697)。在CT和IT受试者之间,术前INR,aPTT或血小板计数无统计学差异(p> 0.138)。抗凝治疗与血栓形成不完全相关(CT为35.5%[38/107],IT为63.9%[23/26]; p = 0.002)。结论影像引导下经皮凝血酶注射液治疗医源性股动脉PSA具有很高的技术成功率和有效率。抗凝治疗是与不完全血栓形成相关的唯一因素。没有影像学因素与技术失败相关,包括肺叶数量(p = 0.898),最大尺寸(p = 0.344)或体积(p = 0.697)。在CT和IT受试者之间,术前INR,aPTT或血小板计数无统计学差异(p> 0.138)。抗凝治疗与血栓形成不完全相关(CT为35.5%[38/107],IT为63.9%[23/26]; p = 0.002)。结论影像引导下经皮凝血酶注射液治疗医源性股动脉PSA具有很高的技术成功率和有效率。抗凝治疗是与不完全血栓形成相关的唯一因素。没有影像学因素与技术失败相关,包括肺叶数量(p = 0.898),最大尺寸(p = 0.344)或体积(p = 0.697)。在CT和IT受试者之间,术前INR,aPTT或血小板计数无统计学差异(p> 0.138)。抗凝治疗与血栓形成不完全相关(CT为35.5%[38/107],IT为63.9%[23/26]; p = 0.002)。结论影像引导下经皮凝血酶注射液治疗医源性股动脉PSA具有很高的技术成功率和有效率。抗凝治疗是与不完全血栓形成相关的唯一因素。CT患者和IT患者之间的血小板计数或血小板计数被发现(p> 0.138)。抗凝治疗与血栓形成不完全相关(CT为35.5%[38/107],IT为63.9%[23/26]; p = 0.002)。结论影像引导下经皮凝血酶注射液治疗医源性股动脉PSA具有很高的技术成功率和有效率。抗凝治疗是与不完全血栓形成相关的唯一因素。CT患者和IT患者之间的血小板计数或血小板计数被发现(p> 0.138)。抗凝治疗与血栓形成不完全相关(CT为35.5%[38/107],IT为63.9%[23/26]; p = 0.002)。结论影像引导下经皮凝血酶注射液治疗医源性股动脉PSA具有很高的技术成功率和有效率。抗凝治疗是与不完全血栓形成相关的唯一因素。
更新日期:2019-11-01
down
wechat
bug